Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vidlin SH"'
Autor:
Gauffin O; Uppsala Monitoring Centre, Uppsala, Sweden., Brand JS; Uppsala Monitoring Centre, Uppsala, Sweden. judith.brand@who-umc.org., Vidlin SH; Uppsala Monitoring Centre, Uppsala, Sweden., Sartori D; Uppsala Monitoring Centre, Uppsala, Sweden., Asikainen S; BCB Medical Ltd, Turku, Finland., Català M; Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Chalabi E; Heliant Ltd, Belgrade, Serbia., Dedman D; Clinical Practice Research Datalink (CPRD), The Medicines and Healthcare Products Regulatory Agency, London, UK., Danilovic A; CHC Zvezdara, Belgrade, Serbia., Duarte-Salles T; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands., García Morales MT; Instituto de Investigación Sanitaria Hospital 12 de Octubre, CIBER de Epidemiología y Salud Pública, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain., Hiltunen S; BCB Medical Ltd, Espoo, Finland., Jödicke AM; Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Lazarevic M; Clinic for cardiac and transplant surgery, University Clinical Center Nis, Nis, Serbia., Mayer MA; Hospital del Mar Medical Research Institute, Parc de Salut Mar, Barcelona, Spain., Miladinovic J; Clinic for infectious diseases, University Clinical Center Nis, University Clinical Center Nis, Nis, Serbia., Mitchell J; Uppsala Monitoring Centre, Uppsala, Sweden., Pistillo A; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain., Ramírez-Anguita JM; Hospital del Mar Medical Research Institute, Parc de Salut Mar, Barcelona, Spain., Reyes C; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain., Rudolph A; Uppsala Monitoring Centre, Uppsala, Sweden., Sandberg L; Uppsala Monitoring Centre, Uppsala, Sweden., Savage R; Uppsala Monitoring Centre, Uppsala, Sweden.; Department of General Practice, University of Otago, Christchurch, New Zealand., Schuemie M; Epidemiology Department, Johnson & Johnson, Titusville, NJ, USA.; Department of Biostatistics, UCLA, Los Angeles, CA, USA., Spasic D; Clinic for cardiac and transplant surgery, University Clinical Center Nis, Nis, Serbia., Trinh NTH; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Veljkovic N; Heliant Ltd, Belgrade, Serbia.; Vinca Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia., Vujovic A; Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., de Wilde M; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands., Zekarias A; Uppsala Monitoring Centre, Uppsala, Sweden., Rijnbeek P; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands., Ryan P; Epidemiology Department, Johnson & Johnson, Titusville, NJ, USA.; Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA., Prieto-Alhambra D; Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands., Norén GN; Uppsala Monitoring Centre, Uppsala, Sweden.
Publikováno v:
Drug safety [Drug Saf] 2023 Dec; Vol. 46 (12), pp. 1335-1352. Date of Electronic Publication: 2023 Oct 07.
Autor:
Rocca E; Uppsala Monitoring Centre, Uppsala, Sweden. elena.rocca@nmbu.no.; Centre for Applied Philosophy of Science, Norwegian University of Life Sciences, Ås, Norway. elena.rocca@nmbu.no., Gauffin O; Uppsala Monitoring Centre, Uppsala, Sweden., Savage R; Uppsala Monitoring Centre, Uppsala, Sweden.; Division of Health Sciences, New Zealand Pharmacovigilance Centre, University of Otago, Dunedin, New Zealand.; Department of General Practice, University of Otago, Christchurch, New Zealand., Vidlin SH; Uppsala Monitoring Centre, Uppsala, Sweden., Grundmark B; Uppsala Monitoring Centre, Uppsala, Sweden. birgitta.grundmark@who-umc.org.
Publikováno v:
Drug safety [Drug Saf] 2021 Sep; Vol. 44 (9), pp. 987-998. Date of Electronic Publication: 2021 Aug 10.
Autor:
Zekarias A; Uppsala Monitoring Centre, Uppsala, Sweden. alem.zekarias@who-umc.org., Watson S; Uppsala Monitoring Centre, Uppsala, Sweden., Vidlin SH; Uppsala Monitoring Centre, Uppsala, Sweden., Grundmark B; Uppsala Monitoring Centre, Uppsala, Sweden.
Publikováno v:
Drug safety [Drug Saf] 2020 Dec; Vol. 43 (12), pp. 1309-1314. Date of Electronic Publication: 2020 Sep 25.